144 ·Filed Jun 12, 2026

TVTX

Travere Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago SEC0001376043-26-000007
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

Monitor for subsequent Form 4 filing to confirm execution. The intent to sell is routine and does not signal negative fundamentals.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
TVTX ▲ +26.96% at T+60d
NEUTRAL call ✓ call won +26.96% · α vs SPY +23.70% · entry $52.04 → $66.07
Entry anchored
Jun 12, 12:20 PM ET
via exchange tick
T+1d
+3.38%
call +3.38% · α +1.62%
$53.80
settled 4mo ago
T+5d
+5.98%
call +5.98% · α +5.30%
$55.15
settled 3mo ago
T+20d
+8.74%
call +8.74% · α +6.96%
$56.59
settled 3mo ago
T+60d
+26.96%
call +26.96% · α +23.70%
$66.07
settled 23d ago

Price Chart

Loading chart...

Executive Summary

Director Timothy Coughlin filed a Form 144 to sell 10,000 common shares of Travere Therapeutics (TVTX), valued at approximately $500,000. The shares stem from options granted in 2018. This is a routine insider sale notice with no material impact on the company's fundamentals.

Key Facts

  • Director Timothy Coughlin intends to sell 10,000 shares of common stock.
  • Estimated market value of the sale is approx. $500,430 based on filing date.
  • Shares acquired from stock options exercised on May 9, 2018.
  • Coughlin previously sold 3,250 shares on May 15, 2026, for ~$141,000.
  • Sale represents a negligible portion of the company's $4.5B market cap.

Financial Impact

Approx. $500,000 sale by a director; immaterial relative to market cap.

dilution

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (21 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001376043-26-000007
Document: 0001376043-26-000007-index.html0001376043-26-000007
Document: 0001376043-26-000007.txt0001376043-26-000007
16 reports for TVTX
Performance horizon
100% Hit rate 7 of 7 directional calls best @ T+60▲ +56.24%Jun 2, 2026
Filters
Rows
Reports for TVTX — sortable, filterable
TypeNow
Jul 9, 2026
12w ago
8-K
NEUTRAL ★ 2/10
$56.59 $61.32▲ +8.36%▲ +5.93%$56.93 (+0.60%)
Jun 16, 2026
15w ago
Insider Cluster
NEUTRAL ★ 2/10
$54.14 $55.28▲ +2.11%▲ +0.79%$56.93 (+5.15%)
Jun 16, 2026
15w ago
8-K
NEUTRAL ★ 2/10
$54.14 $55.28▲ +2.11%▲ +0.79%$56.93 (+5.15%)
Jun 12, 2026
16w ago
144
NEUTRAL ★ 2/10
$52.04 $56.59▲ +8.74%▲ +6.96%$56.93 (+9.40%)
Jun 2, 2026
17w ago
8-K
BULLISH ★ 6/10
$42.96 $56.34▲ +31.15%▲ +32.71%$56.93 (+32.52%)
May 15, 2026
20w ago
144
NEUTRAL ★ 2/10
$42.59 $53.80▲ +26.32%▲ +24.20%$56.93 (+33.67%)
May 5, 2026
21w ago
144
NEUTRAL ★ 2/10
$44.76 $45.20▲ +0.98%▼ −1.80%$56.93 (+27.19%)
May 4, 2026
21w ago
144
NEUTRAL ★ 3/10
$44.80 $42.96▼ −4.11%▼ −9.06%$56.93 (+27.08%)
May 1, 2026
22w ago
Insider Cluster
BEARISH ★ 6/10
$44.12 $45.04▼ −2.09%▲ +3.20%$56.93 (−29.03%)
Apr 15, 2026
24w ago
144
NEUTRAL ★ 3/10
$40.95 $42.84▲ +4.62%▼ −1.43%$56.93 (+39.02%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (38h 30m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access